Effects of 1,1-dimethylguanidine administration on blood pressure, heart rate and renal sympathetic nerve activity in normotensive and spontaneously hypertensive rats

Acta Physiologica Scandinavica

Volumn 159, Issue 1, 1997, Pages 1-6

  Zhang, W ^a,b,c   Pettersson, A ^a,b   Thoren P ^b   Hedner, T ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

1,1 dimethylguanidine; Baroreceptor; L arginine; Nitric oxide; Spontaneously hypertensive rat; Sympathetic nerve activity; Wistar Kyoto rat

Indexed keywords

1,1 DIMETHYLGUANIDINE; ARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; HEART HEMODYNAMICS; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE CONDUCTION; NONHUMAN; PRESSORECEPTOR; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0031021688     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.1997.571334000.x     Document Type: Article

References (36)

1. Arnal, J.F., Battle, T., Menard, J. & Michel, J.B. 1993. The vasodilatory effect of endogenous nitric oxide is a major counter-regulatory mechanism in the spontaneously hypertensive rats. J Hypertens 11, 945-950.
2. Bredt, D.S., Hwang, P.M. & Snyder, S.H. 1990. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347, 768-770.
3. G-nitroarginine in brain in vitro and in vivo. Biochem Biophys Res Commun 176, 1136-1141.
4. Egberongbe, Y.I., Gentleman, S.M., Falkai, P., Bogerts, B., Polak, J.M. & Robert, G.M. 1994. The distribution of nitric oxide synthase immunoreactivity in the human brain. Neuroscience 59, 561-578.
5. Fastier, F.N. & Smirk, F.H. 1947. Circulatory properties of iso-thioureas, guanidines, iso-ureas and amidines. J Pharmacol Exp Ther 89, 256-270.
6. Feng, Q.P. & Hedner, T. 1990. Endothelium-derived relaxing factor (EDRF) and nitric oxide (NO). II. Physiology, pharmacology, and pathophysiological implication. Clin Physiol 10, 503-526.
7. Forstermann, U., Closs, E.I., Pollock, J.S., Nakane, M., Schwarz, P. & Gath, I. 1994. Nitric oxide synthase isozyme. Characterization, purification, molecular cloning, and function. Hypertension 23 (6 pt. 2), 1121-1131.
8. G-monomethyl-L-arginine in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br J Pharmacol 102, 823-826.
9. G-nitro-L-arginine methyl ester on vasodilator responses to adrenaline or BRL 38227 in conscious rats. Br J Pharmacol 104, 731-737.
10. Hasan, K., Heesen, B.J., Corbett, J.A., McDaniel, M.L., Chang, K. & Allison, W. 1993. Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol 249, 101-106.
11. Holm, S. 1979. A simple sequentially rejective multiple test procedure. Scand J Statist 6, 65-70.
12. Jones, L.F. & Brody, M.J. 1992. Coronary blood flow in rats is dependent on the release of vascular nitric oxide. J Pharmacol Exp Ther 260, 627-631.
13. Kelm, M., Feelisch, M., Krebber, T., Motz, W. & Strauer, B.E. 1992. The role of nitric oxide in the regulation of coronary vascular resistance in arterial hypertension: comparison of normotensive and spontaneously hypertensive rats. J Cardiovasc Pharmacol 20 (suppl. 12), S183-S186.
14. Kelm, M., Feelisch, M., Krebber, T., Deussen, A., Motz, W. & Strauer, B.E. 1995. Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats. Hypertension 25, 186-193.
15. Knowles, R.G., Palacios, M., Palmer, R.M.J. & Moncada, S. 1989. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci USA 86, 5159-5162.
16. G-nitro-L-arginine methyl ester-induced hypertension. J Hypertens 12, 791-795.
17. Li, H.B. & Liu, L.S. 1993. Endothelium-derived nitric oxide: role in vascular regulation and interaction with norepinephrine, endothelin and superoxide anion. Chin Med J 106, 258-265.
18. Lowenstein, C.J., Dinerman, J.L. & Snyder, S.H. 1994. Nitric oxide: a physiological messenger. Ann Intern Med 120, 227-237.
19. Lundin, S., Ricksten, S.E. & Thoren, P. 1984. Interaction between 'mental stress' and baroreceptor reflexes concerning effects on heart rate, mean atrial pressure and renal sympathetic activity in conscious spontaneously hypertensive rats. Acta Physiol Scand 120, 273-282.
20. Major, R.H. 1924. Relationship between certain products of metabolism and arterial hypertension. J Am Med Assoc 83, 81-84.
21. Major, R.H. 1925. The possible relationship between guanidine and high blood pressure. Am J Med Sci 170, 228-232.
22. Marietta, M.A. 1989. Nitric oxide: biosynthesis and biological significance. Trends Biochem Sci 14, 488-492.
23. Moncada, S., Palmer, R.M. & Higgs, E.A. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43, 109-142.
24. Moncada, S. 1992. Nitric oxide gas: Mediator, modulator, and pathophysiologic entity. J Lab Clin Med 120, 187-191.
25. Mulvany, M.J. & Nybory, N. 1980. An increased calcium sensitivity of mesenteric resistance vessels in young and adult spontaneously hypertensive rats. Br J Pharmacol 71, 585-595.
26. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J 6, 3051-3064.
27. Rees, D.D., Schulz, R., Hodson, H.F. & Moncada, S. 1990. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101, 746-752.
28. Ricksten, S.E. & Thoren, P. 1980. Reflex inhibition of sympathetic activity during volume load in awake normotensive and spontaneously hypertensive rats. Acta Physiol Scand 112, 169-177.
29. G-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. Circ Res 70, 607-611.
30. G-monomethyl-L-arginine on the blood pressure of pithed normotensive and spontaneously hypertensive rats. Clin Exp Hypertens A14, 527-546.
31. Toda, N., Kitamura, Y. & Okamura, T. 1991. New idea on the mechanism of hypertension: suppression of nitroxidergic vasodilator nerve function. J Vasc Med Biol 3, 235-241.
32. Toda, N., Kitamura, Y. & Okamura, T. 1993. Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs. Hypertension 21, 3-8.
33. Togashi, H., Sakuma, I., Yoshioka, M., Kobayashi, T., Yasuda, H. & Kitabatake, A. 1992. A central nervous system action of nitric oxide in blood pressure regulation. J Exp Pharmacol Ther 262, 343-347.
34. Triggle, C.R. 1994. Is NO the answer? Pharmaceutical News 1, 9-14.
35. van Zwieten, P.A. 1990. Antihypertensive drugs interacting with the sympathetic nervous system and its receptors. In: M.J. Antonaccio et al. (eds) Cardiovascular Drugs and Therapy 3rd edn, pp. 37-73. Raven Press, New York.
36. Vasquez, E.C., Cunha, R.S. & Cabral, A.M. 1994. Baroreceptor reflex function in rats submitted to chronic inhibition of nitric oxide synthesis. Braz J Med Biol Res 27, 767-774.